Syndax Pharmaceuticals SNDX Debt-to-assets
Debt-to-assets at other companies
Other financials
Where this comes from
Calculated from Syndax Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's debt-to-assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's debt-to-assets?
- Syndax Pharmaceuticals (SNDX) reported debt-to-assets of 0.7× in Q1 2026.
- How has Syndax Pharmaceuticals's debt-to-assets changed year-over-year?
- Syndax Pharmaceuticals's debt-to-assets increased by 41.3% year-over-year, from 0.5× to 0.7×.
- What is the long-term trend for Syndax Pharmaceuticals's debt-to-assets?
- Over 5 years (2020 to 2025), Syndax Pharmaceuticals's debt-to-assets has grown at a 242.9% compound annual growth rate (CAGR), from 0× to 0.7×.
- What does debt-to-assets mean?
- Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.